Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood by Scarffe, J. H. et al.
Br. J. Cancer (1980) 41, 764
RELATIONSHIP BETWEEN THE PRETREATMENT PROLIFERATIVE
ACTIVITY OF MARROW BLAST CELLS AND PROGNOSIS OF
ACUTE LYMPHOBLASTIC LEUKAEMIA OF CHILDHOOD
J. H. SCARFFE*, I. M. HANNt, D. I. K. EVANSt, P. MORRIS JONESt,
M. K. PALMERt, J. S. LILLEYMAN§ AND D. CROWTHER*
From the *Cancer Research Campaign Department of Medical Oncology and the
IDepartment of Medical Statistics, Christie Hospital and Holt Radium Institute, Manchester,
the tDepartments ofPaediatric Oncology and Haematology, Royal Manchester Children's
Hospital, Pendlebury, nr. Manchester, and the §Department of Haematology,
Sheffield Children's Hospital, Sheffield
Received 15 November 1979 Accepted 16 January 1980
Summary.-Pretreatment marrow blast cells were studied in 38 boys and 27 girls
(aged 1-14) with acute lymphoblastic leukaemia by flow cytometry after staining
with propidium iodide.
The percentage of blast cells in the S phase of the cell cycle ranged from 1% to 40%
(median 6%). A correlation was found between the percentage of cells in S and the
morphological classification of the French American British Cooperative Group
(FAB), presence of T or B cell markers, haemoglobin concentration, blast size, bone
pain, platelet count, and an inverse correlation with coarse granule and block
staining with Periodic-acid-Schiff (PAS).
63 of the 65 children attained complete remission. During the first 24 months of
follow up there were fewer relapses (P=0-054), and deaths (P=0.004) in those children
with 6% or fewer blasts in S phase. The difference was most marked in the first 12
months with 4 relapses out of 33 in the group with 6% or fewer cells in S compared
with 13/30 in the group with >6% cells in S.
In order to investigate the prognostic significance of the pretreatment proliferative
studies in greater detail, remission duration was correlated with 17 presenting
features. Each feature was correlated individually and then the simultaneous effect
of all the features was assessed by stepwise multiple regression.
Only 3 features of the disease at diagnosis were individually correlated with
duration of remission. These were % cells in S (P<0.001), log white cell blood count
(WBC) (P<0.01) and the presence of T- or B-cell surface markers (P<0.05). However,
the multiple regression analysis showed that cell markers were not an independent
prognostic feature, whereas the percentage cellsin S and log WBC were independently
and significantly correlated with duration of first remission (P<0-001 in each case).
OVER 90% of children with acute prognosis group to unnecessary toxic
lymphoblastic leukaemia (ALL) will treatment, and enable treatment to be
achieve a complete remission with modern modified for those likely to relapse.
chemotherapy. About one half will be A number of prognostic variables are
disease-free at 5 years. Any measurement well recognized. These include age, sex,
at diagnosis which could predict the out- race, initial white blood cell count (WBC),
come of the disease would be important. central nervous system (CNS) disease at
It would prevent exposure of the good- presentation, and the presence of T or B
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cell-surface miarkers (George et al., 1973;
Simone et at., 1975; Miller, 1975; Sen &
Borella, 1975).
The pretreatmenlt in vitro thymidine
labelling index (TLI) of marrow blasts in
acute myelogenous leukaemia in two large
series has shown an inverse relationship
with the length offirst remission (Crowther
et al., 1975; Hart et al., 1977).
The prognostic significance of pretreat-
ment TLI in ALL of childhood is less
clear. Early studies by Foadi (1968) and
Saunders et al. (1967) found no correlation
between TLI and the clinical course ofthe
disease. Nagao (1966) reported an inverse
relationship between TLI and duration of
survival, though his series contained
patienits with both AML and ALL, and
labelling indices were measured both at
diagnosis and relapse. Frei et al. (1975)
demonstrated a positive correlation be-
tween the pretreatment TLI, the number
of blasts in the peripheral blood, and the
fractional reduction in leukaemic cells
with therapy. In another series Gavosto &
Masera (1975) reported an inverse relation-
ship between TLI and survival, but no
correlation with length of first remission.
Interpretation of these studies is difficult
because of the small numbers of cases
studied, and the treatment used would no
longer be considered optimal for long-term
relapse-free survival.
In the largest published series of 94
children with acute leukaemia (71 ALL,
23AML)who hadpretreatment cytokinetic
measurements taken, neither the mitotic
index (MI) nor TLI correlated with the
length of remission (Murphy et al., 1977).
The initial MI and TLI were positively
correlated with each other, but unrelated
to age, initial WBC, or morphological type
of leukaemia. However, the TLI and MI
were significantly higher (P < 0-01) in a
group of 10 children of 54 studied with
ALL whose blast cells were shown to be
T cells by the spontaneous formation of
rosettes with sheep red blood cells at 37°C.
The present study was started in 1974
with the aim ofassessing the possible prog-
nostic role of pretreatment cell-prolifera-
tion studies of marrow blast cells from
children with ALL, and to study the
relationship of these findings to other
prognostic features at presentation. The
almost total replacement of the marrow
with lymphoblasts in most cases make it an
ideal disease for rapid analysis by flow
cytometry. The percentage of cells in the
different phases of the cell cycle can be
rapidly calculated for a large population
of cells within 1 or 2 h of a sample being
taken.
AIATERIALS AND METHODS
Between 1974 and 1978 pretreatment
marrowr aspirates were studied from 71
children (age 1-14 years) with ALL. The
diagnosis was established by routine cyto-
logical and cytochemical staining, and the
morphological appearance of the cells classi-
fied according to the French/American/
British (FAB) classification (Bennett et al.,
1976) as previously described (Hann et al.,
1979).
The patients were all treated with estab-
lished protocols, which included prophylactic
CNS irradiation. The children were entered
into the studies of the Medical Research
Council current at that time. The length of
follow up ranged from 10 to 52 months with a
median of 23 months. The marrow aspirates
w,ere collected into 2 ml of heparinized
Medium 199 (Wellcome Laboratories). After
mixing and centrifuging at 200 g for 5 min the
cell button was resuspended in a small volume
of phosphate-buffered saline (PBS) by gentle
pipetting. Erythrocytes were lysed by the
addition of 5 ml of distilled water, followed
after 10 sec by 0-3M PBS to restore iso-
molarity. The supernatant containing the
red-cell ghosts was carefully removed after
further centrifugation. The cell button was
resuspended in a small volume of PBS and
fixed in 5000 ethanol. Rehydration of the
sample in a graded alcohol series was followed
by digestion in ribonuclease (Sigma) (1 mg/
ml, pH 7 0 at 37°C for 30 min). Propidium
iodide (Calbiochem) (0.05 mg/ml in 101%
sodium citrate) was used to stain the sample
according to the method of Crissman &
Steinkamp (1973).
The stained samples were analysed in a
Model 4800A Cytofluorograf with a Model
2100 Multichannel Distribution Analyser
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(Biophysics Systems Inc., Mahopac, N.Y.).
In this instrument single cells in suspension
pass through a focused argon ion laser beam
(488 nm). For each cell an estimate ofsize was
obtained bymeasuring theforward-anglelight
scatter (1-19°) and of the DNA content by
measuring thelaser-excited fluorescence ofthe
DNA-propidium-iodide complex. These two
measurements were analysed simultaneously
in two electronic channels and displayed as a
scatter diagram. The multichannel distribu-
tion analyser was used to produce a 100-
channel frequency distribution of the DNA
content of at least 10,000 nucleated cells for
each sample. The number of cells in each
channel of the histogram was printed on a
paper tape providing a permanent record
from which the percentage of cells in the
various phases ofthe cell cycle was calculated.
The number of cells in the G1 peak and the
G2+mitosis (M) peak were calculated separ-
ately, and then subtracted from the total
number ofcells in the DNA histogram to give
the percentage of cells in the S phase of the
cell cycle. The number of cells in the G1 peak
was calculated by assuming that the distribu-
tion was almost symmetrical. If we assume
that all the cells to the left ofthe centre ofthe
peak are in G1, the number of G1 cells con-
tributing to the peak is twice that number,
the remainder being made up ofearly S cells.
However, the peak is not always absolutely
symmetrical and the centre ofthe distribution
is not always in the middle of the highest
channel.
If the peak channel is n, and the total
number of cells in the nth channel is An, the
centre of the distribution is at a fraction F
from the left ofthe nth channel where
~An-An_l
F=(An-An-1) +(An-An+)
The sum of the cells in the peak can then be
calculated from the formula
n- 1
Sum=2 [ Ai+F.An
i=l
A similar calculation was performed to calcu-
late the sum of cells in the G2+M peak.
On the same marrow specimen cell-surface
marker studies were performed as previously
described (Kumar et at., 1979). T cells were
identified by spontaneous formation of
rosettes with sheep erythrocytes, and B cells
by direct immunofluorescent staining of
surface immunoglobulins. The periodic-acid-
Schiff (PAS) staining and assessment of blast
size were performed as previously described
(Hann et al., 1979).
Radiological skeletal surveys and bone
pain at presentation were scored as shown in
Table II. Liver and spleen size was measured
in cm below the costal margin. This measure-
ment was confirmed with abdominal X-ray
in most cases. Lymphnode size was assessed
as the diameter of the largest palpable node,
measured in cm.
Comparisons betweentwogroupsofpatients
(e.g. male and female) with respect to the %
cells in the S phase were performed by
Student's t test. Correlation between pairs
ofvariables (e.g. WBC and % S) was measured
by the nonparametric Spearman's rank-
correlation coefficient. Life table survival and
remission-duration curves were compared
using log rank tests (Peto et al., 1977).
Multiple regression analysis was performed
usingthemethod ofCox (1972). Thelogarithm
(log) of WBC was used because of the non-
normality ofthe untransformed values.
RESULTS
Sixty-five of the 71 marrows were
evaluable. Four samples were not evalu-
able because they contained less than 80%
blast cells, and the DNA histogram would
not have been a true representation ofthe
tumour population alone. Two samples
showed such polyploidy that analysis of
the cell-cycle phases was impossible. The
percentage of blast cells in the S phase of
the cell cycle ranged from 1 to 40% with a
mean of 9% and a median of 6%.
The percentage of cells in S was signifi-
cantly higher in those patients grouped
using the FAB classification as L2, when
compared with LI lymphoblastic leuk-
aemia (P< 0.001). The two patients with
L3-type leukaemia had 18 and 20% of
their marrow blast cells in S phase.
Patients with either T or B cell surface
markers had more cells in the S phase than
those whose cells lacked detectable mar-
kers (P< 0'02). When patients with T-cell
disease were compared with non-T, non-B
cell disease, the difference just failed to
reach significance (0.05 >P < 0.1) (see
Table I).
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TABLE I.-Comparison of % cells in S in different presenting groups
Feature
FAB classification
Surface markers
Surface markers
Sex
Group
LI
Non-T Non-B
Non-T Non-B
Male
Studied Group Studied
49
49
49
38
L2
T or B
T
Female
11
13
11
27
p
3-59 < 0-001
2-42 < 0-02
1-91 > 0 05 < 0-01
0-5 N.S.
TABLE II.-Correlation of% cellsinS§with
presentingfeatures
No.
Feature Units studied r+
Haemoglobin
Blast size
Bone pain
Platelet count
PAS Staint
PB Blasts at 72 h
Time to remission
Age
WBC
Uric Acid
Lympho-
'denopathy
X-ray bone
lesions
Splenomegaly
Hepatomegaly
g/dl
,um
*
x 109/1
% +ve
Days
Years
x 109/1
mmol/l
65
51
64
65
63
53
56
65
65
64
cm 58
t 35
cm 63
cm 65
0-40
0 40
0-29
0-26
-0-25
0-23
-0-21
-0-19
0-17
0-16
0-12
0-11
0-08
0-08
p
< 0-001
< 0-001
<0-02
< 0 05
<005
N.S.
* 0 =nil, 1 =mild, 2 =moderate, 3 =severe.
t Periodic-acid-Schiff coarse granules and blocks.
I 0=None, 1 =minimal change, 2 = 1-2 bones,
3 =3, 4 or 5 bones, 4= > 5 bones irnvolved.
§ The correlation between % cells in S and other
presenting features was measured by the nonpara-
metric Spearman's rho (p) rank-correlation co-
efficient.
The percentage of cells in S at presenta-
tion correlated strongly with the haemo-
globin concentration and blast size (r=
0-40, P< 0-001 for both). There was a less
strong correlation with bone pain (r= 0-29,
P < 0.02) and platelet count (r=0-26,
P< 0.05). There was an inverse relation-
ship between the percentage of cells in S
and the percentage of cells which after
staining with PAS contained coarse
granules or block positivity (r=-025,
P<0.05).
There was no significant correlation
between the percentage cells in S with the
percentage of peripheral blood blast cells
remaining at 72 h after the start of treat-
ment, the length oftime to attain complete
remission, age, WBC, uric acid, lymphnode
size, bone X-ray changes, or the size of
enlarged liver or spleen (Table II).
Sixty-three of the 65 children (97%)
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Fia. 1.-Duration offirst remission from ALL
for 33 children with 0-6% marrow blast
cells in S and 30 children with > 6% cells
in S (P= 0-054).
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FIG. 2. Survival curves for 33 children with
0-6% marrow blast cells in S and 32
children with > 6% blast cells in S (P=
0.0042).
attained complete remission. No com-
parison between pretreatment cell pro-
liferation information and response can be
made with only 2 treatment failures, one
ofwhom died within 24 h of presentation.
To assess the prognostic significance of
the pretreatment proliferation studies, the
children were divided into 2 groups, those
with more than the median (6%) percent-
age cells in S and those with 6% or fewer.
There were fewer relapses (P=0.054) and
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deaths (P= 0.004) during the first 24
months offollow-up in those children with
60% or less blasts in S (Figs 1 & 2). The
differences were most marked in the first
12 months, with 4 relapses out of 30
children in the group with a lower propor-
tion in S compared with 13/30 children in
the group with > 6% in S. All the children
with > 6% in S died soon after their
relapse, whereas 4/9 relapses in the group
with 6% or less in S continued into a
second remission.
In order to study the prognostic signifi-
cance of the pretreatment proliferation
studies in more detail, and to take into
account other prognostic factors, re-
mnission duration was correlated with the
actual percentage of cells in S (rather than
divided simply into groups above and
below the median) and all the other pre-
senting features shown in Tables I and II,
using a regression method. Each factor
was correlated individually, and then the
simultaneous effect of all the features was
assessed by stepwise multiple regression.
Only 3 features of the disease at diag-
nosis showed a statistically significant
correlation with duration of remission.
These were 00 cells in S (P<0.0001), log
WBC (P < 0-01) and the presence of T- or
B-cell surface markers (P < 0.05). The
multiple regression analysis demonstrated
that the presence of T or B cell-surface
markers was not an independent prog-
nostic feature, whereas the percentage
cells in S and the log WBC were independ-
ently and significantly correlated with
duration of first remission (P < 0-001 for
each factor).
DISCUSSION
Flow cytometry proved to be a rela-
tively simple and fast method ofobtaining
cell-proliferative data. The range and the
median percentage of bone marrow blast
cells in S was similar to the TLI reported
by other workers in ALL of childhood
(Saunders et al., 1967; Foadi et al., 1968;
Frei et al., 1975; Gavosto & Masera 1975;
Murphy et al., 1977).
It has been shown in previous studies
that there is a clear correlation between
TLI and the proportion of large blast cells
in the marrow (Saunders et al., 1967;
Gavosto et al., 1.967; Frei et al., 1975;
Masera & Matera, 1976). There was a
strong correlation between size and the
percentage of cells in S in the present
study (P < 0-001). Size is one of the
criteria used in the FAB classification to
distinguish LI from L2 disease. Cells in
L2 are described as large and hetero-
geneous. It was interesting therefore that
patients with L2 disease have a signifi-
cantly higher percentage ofcells in S phase
than those with LI disease. The prognostic
significance of cell size is controversial.
Mathe et at. (1973) described a morpho-
logical classification in which size was an
important criterion. Patients with larger
cells had a poor prognosis. This inverse
relationship between lymphoblast size and
duration of first remission was confirmed
by Pantazopoulos & Sinks (1974). How-
ever, 3 other large series have failed to
show any correlation between size and
prognosis (Jacquillat et al., 1973; Murphy
et al., 1975; Oster et al., 1976). Reports of
the usefulness of the FAB classification
are beginning to appear in the literature.
In a large study of 566 children reported
by Miller et al. (1979) and analysed by
multivariate analysis, the FAB classifica-
tion was the most important prognostic
factor. A smaller study of 101 children
confirmed the prognostic value of the
classification (Wagner & Baehmer, 1979).
In our series, the patient group with blast
cells bearing T or B cell-surface markers
had a significantly higher percentage of
cells in S than those that were marker-
negative. When patients with T-cell
disease alone were compared with those
without markers the difference just failed
to reach statistical significance. Within
the T-cell group there was a wide range of
percentage in S, from 4 to 40%o. High
TLIs have been reported previously by
other workers in T-cell disease (Tsukimoto
et al., 1976; Murphy et al., 1977).
There was an inverse correlation be-
tween the percentage of cells in S and the
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percentage which contained PAS+ coarse
granules and blocks. Children with a low
percentage of marrow blast cells in S, who
in this study had a better prognosis, also
had more PAS+t cells. The role of PAS as
a prognostic factor is unclear. The studies
by Laurie (1968), Vowels & Willoughby
(1973), Feldges et al. (1974), Ascari et al.
(1975) and the recent studies by Lilleyman
et al. (1979) and Hann et al. (1979) found
that the prognosis was better for those
patients with a high percentage of PAS+
cells. However, the studies of Bennett &
Henderson (1969), Berrebi et al. (1973),
Humphrey et al. (1974), Shaw et al. (1977)
and others found no prognostic value in
PAS staining.
The correlation between the 0 cells in
S and haemoglobin concentration and
platelet count was interesting. Perhaps
children with a more aggressive form of
ALL present early, before their platelet
count and haemoglobin concentration
have had time to drop. Saunders et al.
(1967) reported that in children with a
TLI > 6% the duration of symptoms was
less than 2 weeks before diagnosis,
whereas children with symptoms of more
than 2 weeks' duration had a TLI < 6%.
Patients who present with a high haemo-
globin have tended to have a poor prog-
nosis in a number of series (Londsale et al.,
1975; Simone et al., 1975; Zippin et al.,
1975). A recent multivariate analysis of
566 children showed the haemoglobin
concentration to be the third most im-
portant prognostic factor, after morph-
ology and age (Miller et al., 1979). Most
studies have found that a low platelet
count was a bad prognostic factor, but the
advent of readily available platelet trans-
fusions has probably changed this, and
Miller's study found the platelet count
unhelpful as a prognostic indicator.
Simone et al. (1975) point out the inverse
relationship of platelet count and white
blood cell count. The WBC is a well
documented prognostic indicator, so that
in a more complex analysis the significance
of platelet count is likely to be obliterated
when allowance is made for WBC.
There was no correlation between the
percentage cells in S and the tumour-cell
mass as represented by WBC, size of
lymph nodes, spleen or liver. This lack of
correlation confirms the finding of Saun-
ders et al. (1967), Foadi et al. (1968) and
Murphy et al. (1977). Frei et al. (1975) did,
however, find a positive correlation be-
tween WBC and TLI in their 23 cases.
When the prognostic importance of
percentage cells in S was studied by
dividing the children into two equal
groups about the median, the difference in
remission length just failed to reach sig-
nificance (P=0.054) but was statistically
significant for survival (P= 0004). How-
ever, when the more sensitive multivariate
analysis was performed for length of first
remission, the percentage cells in S became
a highly significant prognostic factor
(P < 0 001) along with the log WBC
(P < 0 01) and the presence of T or B cell-
surface markers (P< 0.05). After adjust-
ment for the interrelationship among the
variables, the cell-surface markers were
no longer independent prognostic features,
whereas the percentage cells in S phase,
and the log WBC were independently and
significantly correlated with the duration
of the first remission (P < 0-001 for each
variate). The loss of the significance ofthe
surface-marker studies was not surprising,
since this group has been clearly shown to
be associated with high WBC and high
labelling indices at presentation.
The majority of the relapses in the
group with a high 00 5 phase occurred
early within the first 12 months of treat-
ment. The children were all on main-
tenance treatment at this time. Hart et al.
(1977) suggested several explanations for
this early relapse in patients with high
proliferative activity in the pretreatment
marrow. An initially rapid cell turnover
continued during therapy could produce a
rapid increase in the number of leukaemic
cells once therapy was no longer effective.
Also, rapidly proliferating cells may de-
velop resistance to chemotherapeutic
agents more quickly than more slowly
proliferating cells.
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The pretreatment proliferative activity
of marrow blast cells assessed by TLI was
of no prognostic value in the 64 children
with ALL studied by Murphy et al. (1977).
The number of children studied, treat-
ment, and length of follow-up were com-
parable with the present study. Despite
the different methods used in the two
studies to identify cells in S, the range and
median % cells in S were similar. Murphy
and co-workers did not use a multivariate
analysis, and it is possible that the prog-
nostic significance of the TLI may have
been masked by a strong prognostic factor
such as WBC.
The prognostic value of pretreatment
cell proliferation studies is still contro-
versial, and further studies are required to
clarify the situation. Flow-cytometry tech-
niques can be used in these studies and can
also measure other cell characteristics
(such as cell size and RNA content)
simultaneously. These objective and
quantitative studies will hopefully help to
identify new factors affecting prognosis in
ALL ofchildhood.
The authors wish to thank T. Carr and Dr. S.
Kumar for the surface marker studies and Mrs
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